Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsReceivables - NetShares Repurchased
Ratios

Niagen Bioscience (NAGE) Leases (2019 - 2025)

Niagen Bioscience (NAGE) has disclosed Leases for 7 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Leases rose 27.17% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, up 27.17% year-over-year, with the annual reading at $2.2 million for FY2025, 27.17% up from the prior year.
  • Leases for Q4 2025 was $2.2 million at Niagen Bioscience, down from $2.4 million in the prior quarter.
  • The five-year high for Leases was $4.4 million in Q4 2021, with the low at $1.7 million in Q4 2024.
  • Average Leases over 5 years is $2.9 million, with a median of $3.0 million recorded in 2023.
  • The sharpest move saw Leases surged 353.9% in 2021, then tumbled 36.76% in 2024.
  • Over 5 years, Leases stood at $4.4 million in 2021, then dropped by 20.45% to $3.5 million in 2022, then crashed by 31.43% to $2.4 million in 2023, then decreased by 27.92% to $1.7 million in 2024, then grew by 27.17% to $2.2 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $2.2 million, $2.4 million, and $2.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.